HIMS
Hims & Hers Health, Inc.
NYSEUSDEQUITY
Healthcare
DELAYED
Buy
+25/100
Last price
29.49
▼ 0.18 (0.61%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
29.89
Prev close
29.67
Day high
30.08
Day low
29.07
Volume
8.80M
Market cap
$6.88B
P/E (TTM)
—
52W range
13.74 – 65.30
Day trading desk
Gap from prior close
+0.74%
Prior close 29.67
VWAP
29.44
+0.18% from price
Relative volume
0.61×
Normal
Session range
3.72%
29.07 – 30.15
Position in range
39%
Mid range
ATR (14D)
1.66
5.64% of price
Prior day high
30.04
PDH
Prior day low
28.80
PDL
Bid / ask spread
—
Quote not published
Session volume
7.35M
Avg 12.12M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+2.68%
+0.7%
1M
+6.35%
+5.2%
3M
-18.30%
-22.8%
6M
+51.13%
+32.9%
YTD
-9.24%
-23.5%
1Y
-43.91%
-60.3%
3Y
+368.52%
+286.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
11 more panels on HIMS open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+2.03M
Net buying
Buy transactions
39
2.40M shares
Sell transactions
20
376.91K shares
Net transactions
+59
Buys less sells
Sell : buy shares
0.2 : 1
Mixed
Insider-held shares
11.54M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 22, 26 | OKUPE OLUYEMI Chief Financial Officer |
CONVERSION | 14.00K | $70.14K | Direct |
| Sep 22, 26 | OKUPE OLUYEMI Chief Financial Officer |
SELL | 29.28K | $876.85K | Direct |
| Sep 16, 26 | BOUGHTON SOLEIL Officer |
SELL | 6.24K | $173.74K | Direct |
| Sep 15, 26 | ELSHENAWY MOHAMED Chief Technology Officer |
SELL | 7.95K | $225.81K | Direct |
| Sep 15, 26 | CHI MICHAEL Y Chief Operating Officer |
SELL | 14.03K | $398.23K | Direct |
| Sep 2, 26 | BOUGHTON SOLEIL Officer |
SELL | 3.46K | $97.97K | Direct |
| Aug 25, 26 | DUDUM ANDREW Chief Executive Officer |
STOCK | 463.29K | $0 | Indirect |
| Aug 19, 26 | OKUPE OLUYEMI Chief Financial Officer |
CONVERSION | 4.94K | $24.74K | Direct |
| Aug 19, 26 | OKUPE OLUYEMI Chief Financial Officer |
SELL | 4.94K | $148.11K | Direct |
| Aug 19, 26 | BOUGHTON SOLEIL Officer |
SELL | 25.11K | $691.81K | Direct |
| Aug 18, 26 | AUTOR DEBORAH M Officer and Director |
SELL | 16.77K | $467.13K | Direct |
| Aug 17, 26 | OKUPE OLUYEMI Chief Financial Officer |
CONVERSION | 81.00K | $47.03K | Direct |
| Aug 17, 26 | OKUPE OLUYEMI Chief Financial Officer |
SELL | 64.77K | $2.21M | Direct |
| Aug 14, 26 | WELLS DAVID B Director |
— | 778 | — | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BAIRD MELISSA |
Chief Operating Officer | 805.08K | Conversion of Exercise of derivative security |
BOUGHTON SOLEIL |
Officer | 304.27K | Sale |
CARROLL PATRICK HARRISON |
Officer | 197.85K | Conversion of Exercise of derivative security |
CHI MICHAEL Y |
Chief Operating Officer | 456.66K | Sale |
DUDUM ANDREW |
Chief Executive Officer | — | Stock Gift |
ELSHENAWY MOHAMED |
Chief Technology Officer | 185.56K | Sale |
OKUPE OLUYEMI |
Chief Financial Officer | 244.38K | Conversion of Exercise of derivative security |
PAYNE CHRISTOPHER D |
Director | 144.86K | Conversion of Exercise of derivative security |
PEREZ GARCIA ANDREA G |
Director | 83.82K | Conversion of Exercise of derivative security |
WELLS DAVID B |
Director | 229.81K | Conversion of Exercise of derivative security |
Fundamentals
Market cap$6.88B
Enterprise value$7.58B
Revenue (TTM)$2.58B
Gross profit$1.79B
EBITDA$-10.18M
Net income$-142.03M
EPS (TTM)$-0.64
Free cash flow$849.44M
Total cash$841.05M
Total debt$1.55B
Book value / share$1.39
Shares outstanding224.94M
Float213.75M
Short % of float27.26%
Dividend yield0.00%
Beta (5Y)2.43
Valuation & profitability ratios
Trailing P/E—
Forward P/E39.97
PEG ratio2.71
Price / sales—
Price / book21.22
EV / revenue2.94
EV / EBITDA-744.91
Gross margin69.53%
Operating margin-12.75%
Profit margin-5.51%
Return on equity-32.03%
Return on assets-2.21%
Debt / equity477.13
Current ratio0.93
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $2.35B | $1.48B | $872.00M | $526.92M | — | +59.0% |
| Operating revenue | $2.35B | $1.48B | $872.00M | $526.92M | — | +59.0% |
| Cost of revenue | $614.26M | $303.38M | $157.05M | $118.19M | — | +102.5% |
| Gross profit | $1.73B | $1.17B | $714.95M | $408.72M | — | +47.8% |
| Research & development | $149.30M | $78.82M | $48.23M | $29.24M | — | +89.4% |
| Selling, general & admin | $1.19B | $846.61M | $576.32M | $370.78M | — | +40.8% |
| Total operating expense | $1.63B | $1.11B | $744.40M | $477.42M | — | +46.5% |
| Operating income | $105.61M | $61.90M | -$29.45M | -$68.70M | — | +70.6% |
| Net interest income | — | — | — | — | $0 | — |
| Pre-tax income | $123.92M | $71.71M | -$21.57M | -$65.71M | — | +72.8% |
| Tax provision | -$4.44M | -$54.33M | $1.98M | -$31.00K | — | +91.8% |
| Net income | $128.37M | $126.04M | -$23.55M | -$65.68M | — | +1.8% |
| Net income to common | $128.37M | $126.04M | -$23.55M | -$65.68M | — | +1.8% |
| Basic EPS | 0.57 | 0.58 | -0.11 | -0.32 | — | -1.7% |
| Diluted EPS | 0.51 | 0.53 | -0.11 | -0.32 | — | -3.8% |
| EBIT | $105.61M | $61.90M | -$29.45M | -$68.70M | — | +70.6% |
| EBITDA | $160.12M | $78.99M | -$19.94M | -$61.22M | — | +102.7% |
| Basic shares | 224.96M | 215.94M | 209.34M | 204.52M | — | +4.2% |
| Diluted shares | 258.23M | 236.81M | 209.34M | 204.52M | — | +9.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $228.62M | $220.58M | $96.66M | $46.77M | +3.6% |
| Cash & short-term investments | $577.49M | $300.25M | $220.98M | $179.63M | +92.3% |
| Accounts receivable | $32.15M | $6.08M | $6.75M | $3.23M | +428.8% |
| Inventory | $80.13M | $64.43M | $22.46M | $21.56M | +24.4% |
| Total current assets | $767.64M | $395.83M | $265.05M | $216.59M | +93.9% |
| Property, plant & equipment | $448.98M | $92.96M | $45.73M | $16.14M | +383.0% |
| Goodwill & intangibles | $474.44M | $156.14M | $129.46M | $132.72M | +203.9% |
| Total assets | $2.15B | $707.54M | $441.19M | $366.34M | +204.5% |
| Total current liabilities | $404.43M | $221.37M | $88.47M | $47.94M | +82.7% |
| Long-term debt | $972.58M | — | — | — | — |
| Total debt | $1.12B | $11.35M | $9.95M | $5.31M | +9,777.4% |
| Total liabilities | $1.61B | $230.82M | $97.16M | $54.60M | +599.1% |
| Retained earnings | -$113.77M | -$242.14M | -$368.18M | -$344.63M | +53.0% |
| Shareholder equity | $540.93M | $476.72M | $344.03M | $311.74M | +13.5% |
| Working capital | $363.21M | $174.46M | $176.59M | $168.65M | +108.2% |
| Net tangible assets | $66.49M | $320.58M | $214.57M | $179.02M | -79.3% |
| Shares issued | 227.25M | 220.84M | 213.48M | 208.43M | +2.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $128.37M | $126.04M | -$23.55M | -$65.68M | +1.8% |
| Depreciation & amortisation | $54.50M | $17.09M | $9.52M | $7.47M | +218.9% |
| Stock-based compensation | $135.24M | $92.32M | $66.08M | $42.82M | +46.5% |
| Change in working capital | -$29.16M | $78.62M | $20.82M | -$14.20M | -137.1% |
| Operating cash flow | $300.01M | $251.08M | $73.48M | -$26.53M | +19.5% |
| Capital expenditure | -$242.59M | -$52.75M | -$26.49M | -$7.25M | -359.9% |
| Investing cash flow | -$1.02B | -$19.05M | -$12.11M | $34.70M | -5,280.9% |
| Share buybacks | -$89.96M | -$83.04M | -$2.00M | $0 | -8.3% |
| Financing cash flow | $729.62M | -$107.84M | -$11.47M | -$33.13M | +776.5% |
| Free cash flow | $57.41M | $198.33M | $46.99M | -$33.78M | -71.1% |
| End cash position | $228.62M | $221.44M | $97.52M | $47.63M | +3.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $753.21M | $608.10M | $617.82M | $598.98M | $544.83M | +23.9% |
| Operating revenue | $753.21M | $608.10M | $617.82M | $598.98M | $544.83M | +23.9% |
| Cost of revenue | $272.41M | $211.32M | $173.38M | $156.92M | $128.64M | +28.9% |
| Gross profit | $480.80M | $396.79M | $444.44M | $442.06M | $416.20M | +21.2% |
| Research & development | $54.90M | $46.94M | $40.96M | $40.58M | $37.85M | +17.0% |
| Selling, general & admin | $427.61M | $331.67M | $314.21M | $312.83M | $285.13M | +28.9% |
| Total operating expense | $578.00M | $475.11M | $435.25M | $430.25M | $389.47M | +21.7% |
| Operating income | -$97.19M | -$78.32M | $9.19M | $11.81M | $26.72M | -24.1% |
| Pre-tax income | -$92.63M | -$101.55M | $18.35M | $12.22M | $32.85M | +8.8% |
| Tax provision | -$6.34M | -$9.44M | -$2.25M | -$3.55M | -$9.65M | +32.8% |
| Net income | -$86.29M | -$92.11M | $20.60M | $15.77M | $42.51M | +6.3% |
| Net income to common | -$86.29M | -$92.11M | $20.60M | $15.77M | $42.51M | +6.3% |
| Basic EPS | -0.37 | -0.40 | 0.09 | 0.07 | 0.19 | +7.5% |
| Diluted EPS | -0.37 | -0.40 | 0.08 | 0.06 | 0.17 | +7.5% |
| EBIT | -$97.19M | -$78.32M | $9.19M | $11.81M | $26.72M | -24.1% |
| EBITDA | -$67.72M | -$56.37M | $27.28M | $29.48M | $37.19M | -20.1% |
| Basic shares | 231.75M | 228.36M | 227.06M | 226.35M | 224.37M | +1.5% |
| Diluted shares | 231.75M | 228.36M | 248.10M | 248.68M | 256.78M | +1.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $609.81M | $222.27M | $228.62M | $345.78M | $1.12B | +174.4% |
| Cash & short-term investments | $841.05M | $750.88M | $577.49M | $629.74M | $1.14B | +12.0% |
| Accounts receivable | $375.29M | $149.62M | $32.15M | $41.33M | $6.74M | +150.8% |
| Inventory | $87.78M | $79.07M | $80.13M | $105.99M | $141.80M | +11.0% |
| Total current assets | $1.38B | $1.05B | $767.64M | $845.26M | $1.36B | +32.5% |
| Property, plant & equipment | $529.78M | $478.09M | $448.98M | $406.74M | $277.14M | +10.8% |
| Goodwill & intangibles | $1.52B | $603.87M | $474.44M | $454.17M | $158.41M | +152.5% |
| Total assets | $3.63B | $2.27B | $2.15B | $2.23B | $1.88B | +60.1% |
| Total current liabilities | $1.48B | $618.78M | $404.43M | $450.79M | $272.23M | +139.7% |
| Long-term debt | $1.37B | $974.11M | $972.58M | $971.02M | $969.47M | +40.2% |
| Total debt | $1.55B | $1.13B | $1.12B | $1.12B | $1.04B | +36.6% |
| Total liabilities | $3.30B | $1.82B | $1.61B | $1.65B | $1.31B | +81.5% |
| Retained earnings | -$292.18M | -$205.89M | -$113.77M | -$134.37M | -$150.15M | -41.9% |
| Shareholder equity | $324.07M | $446.17M | $540.93M | $580.98M | $562.70M | -27.4% |
| Working capital | -$98.62M | $426.59M | $363.21M | $394.48M | $1.08B | -123.1% |
| Net tangible assets | -$1.20B | -$157.71M | $66.49M | $126.81M | $404.29M | -661.2% |
| Shares issued | 233.30M | 230.70M | 227.25M | 227.50M | 225.76M | +1.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | -$86.29M | -$92.11M | $20.60M | $15.77M | $42.51M | — | +6.3% |
| Depreciation & amortisation | $29.48M | $21.95M | $18.09M | $17.67M | $10.46M | — | +34.3% |
| Stock-based compensation | $42.12M | $36.86M | $34.49M | $40.17M | $35.73M | — | +14.3% |
| Change in working capital | -$35.74M | $67.45M | -$12.04M | $60.12M | -$101.53M | — | -153.0% |
| Operating cash flow | -$35.94M | $89.36M | $61.31M | $148.72M | -$19.12M | — | -140.2% |
| Capital expenditure | -$32.25M | -$36.32M | -$63.88M | -$69.36M | -$50.31M | — | +11.2% |
| Investing cash flow | $84.54M | -$15.45M | -$83.68M | -$887.40M | -$21.09M | — | +647.3% |
| Share buybacks | — | — | -$80.48M | -$9.48M | $0 | $0 | — |
| Financing cash flow | $341.76M | -$77.88M | -$97.52M | -$39.01M | $889.17M | — | +538.8% |
| Free cash flow | -$68.19M | $53.03M | -$2.57M | $79.36M | -$69.43M | — | -228.6% |
| End cash position | $609.81M | $222.27M | $228.62M | $345.78M | $1.12B | — | +174.4% |
Options analytics
Put / call volume
0.46
Call-heavy session
Put / call open interest
0.35
Positioning, not flow
Max pain
29.00
-1.6% from spot
ATM implied vol
69.9%
Nearest strike to spot
Skew (10% OTM)
-4.3%
Calls bid over puts
Call volume
9.36K
Contracts, this expiry
Put volume
4.27K
Contracts, this expiry
Heaviest call OI
29.50
5.35K contracts
Heaviest put OI
27.00
3.23K contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.05 | -0.37 | -640.0% |
| Mar 2026 | 0.03 | -0.40 | -1,664.3% |
| Dec 2025 | 0.04 | 0.08 | +92.5% |
| Sep 2025 | 0.10 | 0.06 | -41.0% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.06 | 11 | $892.77M | +49.1% |
| Next quarter | 0.11 | 11 | $954.58M | +54.5% |
| Current year | -0.56 | 11 | $3.21B | +36.7% |
| Next year | 0.42 | 11 | $4.00B | +24.6% |
Analyst targets & ownership
Mean target$31.15
High target$42.00
Low target$23.00
Implied upside5.64%
Analyst count13
ConsensusHOLD
Strong buy / Buy2 / 1
Hold11
Sell / Strong sell0 / 1
Held by insiders4.95%
Held by institutions71.14%
Institutions holding670
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
29.18
+1.06% from price
SMA 20
28.75
+2.51% from price
SMA 50
29.31
+0.55% from price
SMA 100
29.86
-1.26% from price
SMA 200
27.48
+7.25% from price
EMA 12
29.18
+1.07% from price
EMA 26
29.16
+1.12% from price
EMA 50
29.42
+0.24% from price
RSI (14)
51.5
Neutral
MACD (12,26,9)
0.02
Hist 0.16
ATR (14)
1.66
5.64% of price
Realised vol 30D
54.9%
Annualised
Bollinger upper
30.39
20, 2σ
Bollinger lower
27.10
20, 2σ
50 / 200 cross
Golden
29.31 vs 27.48
Trend bias
Above 200
+7.25%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
2.66
More volatile than market
Correlation to SPY
0.38
Loosely linked
Realised vol 30D
54.9%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-76.9%
Peak to trough
Max drawdown 5Y
-78.9%
Peak to trough
ATR 14
1.66
5.64% of price
Beta (reported)
2.43
5Y monthly, from filing
Short interest
Shares short
52.92M
Prior 58.67M
Change vs prior
-9.8%
Shorts covering
% of float
27.26%
Heavily shorted
% of shares out
22.68%
Against total outstanding
Days to cover
4.9
Liquid
Float
213.75M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 24, 26 | Truist Securities | MAINTAINED | Hold | Hold |
| Aug 21, 26 | Barclays | MAINTAINED | Overweight | Overweight |
| Aug 11, 26 | Citigroup | MAINTAINED | Neutral | Neutral |
| Aug 11, 26 | Deutsche Bank | MAINTAINED | Hold | Hold |
| Aug 11, 26 | B of A Securities | MAINTAINED | Neutral | Neutral |
| Aug 11, 26 | TD Cowen | MAINTAINED | Hold | Hold |
| Aug 11, 26 | Morgan Stanley | MAINTAINED | Equal-Weight | Equal-Weight |
| Aug 11, 26 | Needham | MAINTAINED | Buy | Buy |
| Jul 24, 26 | Truist Securities | MAINTAINED | Hold | Hold |
| Jul 23, 26 | Citigroup | MAINTAINED | Neutral | Neutral |
| Jul 9, 26 | B of A Securities | MAINTAINED | Neutral | Neutral |
| Jul 1, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-08-10
Corporate Changes & Voting Matters
8-K · 2026-07-17
Corporate Changes & Voting Matters
8-K · 2026-07-01
Corporate Changes & Voting Matters
8-K · 2026-06-15
Corporate Changes & Voting Matters
8-K · 2026-06-02
Corporate Changes & Voting Matters
8-K · 2026-05-21
Corporate Changes & Voting Matters
8-K · 2026-05-19
Periodic Financial Reports
10-Q · 2026-05-11
Headlines
2 Cash-Producing Stocks to Research Further and 1 We Find Risky
StockStory · 15h ago
Arboretum Launches to Redefine Precision Medicine for Common Diseases as a Next-Generation Molecular Information Company
Business Wire · 17h ago
How Investors May Respond To Hims & Hers Health (HIMS) Appointing Regional Chief Medical Officers For Global Expansion
Simply Wall St. · 2d ago
Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It
Zacks · 2d ago
Robinhood’s Tokenized Stocks Are Becoming a New Memecoin Trade: Report
CryptoProwl · 5d ago
Hims & Hers Health, Inc. (HIMS) Stock Slides as Market Rises: Facts to Know Before You Trade
Zacks · 5d ago
Hims & Hers Names Chief Medical Officers in the UK and Australia, Deepening its Investment in Local Clinical Leadership
Business Wire · 6d ago
Hims & Hers Stock: 30% Growth Can’t Hide a Margin Problem
TIKR · 8d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.